BridgeBio Pharma: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $168.1 million in its fourth quarter.

The Palo Alto, California-based company said it had a loss of 96 cents per share.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.

The rare disease drug developer posted revenue of $1.7 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $6.9 million.

For the year, the company reported that its loss widened to $643.2 million, or $3.95 per share. Revenue was reported as $9.3 million.

BridgeBio Pharma shares have fallen 15% since the beginning of the year. The stock has nearly tripled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BBIO at https://www.zacks.com/ap/BBIO

Advertisement

Recommended Stories